WallStSmart
WHWK

Whitehawk Therapeutics, Inc.

NASDAQ: WHWK · HEALTHCARE · BIOTECHNOLOGY

$4.04
-2.18% today

Updated 2026-04-29

Market cap
$194.92M
P/E ratio
P/S ratio
27.28x
EPS (TTM)
$-0.33
Dividend yield
52W range
$1 – $4
Volume
0.2M

WallStSmart proprietary scores

24
out of 100
Grade: F
Strong Sell
Investment rating
2.7
Growth
F
6.0
Quality
B
2.0
Profitability
F
5.0
Valuation
C+
3/9
Piotroski F-Score
Weak
Altman Z-Score
Industry rank
View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target
$6.25
+54.70%
12-Month target
Intrinsic (DCF)
Margin of safety
0 Strong Buy2 Buy3 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths
Insufficient data
Risks
- Piotroski 3/9 — weak financial health
- Thin margins at -288.30%
- Negative free cash flow $-17.23M
- Revenue declining -100.00% QoQ

Key financials

Revenue Net Income Free Cash Flow
Metric2022202320242025TTM
Revenue$15.22M$24.35M$25.98M$7.14M$7.14M
Net income$-60.51M$-65.77M$-63.69M$-20.60M$-23.25M
EPS$-0.33
Free cash flow$-50.08M$-63.63M$-61.20M$-97.98M$-17.23M
Profit margin-397.69%-270.04%-245.13%-288.26%-288.30%

Peer comparison

CompanyMkt CapScoreGrowthProfitValueQualityMoSRating
WHWK$194.92M242.72.05.06.0Avoid
LLY$760.43B7810.010.05.06.5Strong Buy
JNJ$547.28B594.79.03.36.0-43.54%Buy
ABBV$360.63B634.08.04.75.0-29.31%Buy
UNH$336.47B545.35.57.34.8+42.09%Buy
AZN$287.11B646.78.05.35.0+4.07%Buy

Smart narrative

Whitehawk Therapeutics, Inc. trades at $4.04. Our Smart Value Score of 24/100 indicates the stock is weak. The company scores 3/9 on the Piotroski F-Score. TTM revenue stands at $7.14M. with profit margins at -288.30%.

Frequently asked questions

What is Whitehawk Therapeutics, Inc.'s stock price?
Whitehawk Therapeutics, Inc. (WHWK) trades at $4.04.
Is Whitehawk Therapeutics, Inc. overvalued?
Smart Value Score 24/100 (Grade F, Strong Sell).
What is the price target of Whitehawk Therapeutics, Inc. (WHWK)?
The analyst target price is $6.25, representing +54.7% upside from the current price of $4.04.
What is Whitehawk Therapeutics, Inc.'s revenue?
TTM revenue is $7.14M.
Piotroski F-Score?
3/9 — weak financial health.

Company info

SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD

Quick metrics

P/S ratio27.28x
ROE-21.80%
Beta0.62
50D MA$3.63
200D MA$2.57
Shares out0.05B
Float0.02B
Short ratio
Avg volume0.2M

Performance

1 week
1 month
3 months
YTD
1 year
3 years
5 years